Pharmacological Investigation of Certain Valeriana officinalis L. Extracts

Pharmacological Investigation of Certain Valeriana officinalis L. Extracts

The roots of Valeriana officinalis were extracted by various solvent extraction procedures and the fractions prepared were tested for their biological activity in an attempt to isolate the most active constituents. Two fractions, V103 and V115, both showed some ability to potentiate the pentobarbita...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of pharmaceutical sciences 1961-03, Vol.50 (3), p.240-244
Hauptverfasser: Rosecrans, J.A., Defeo, J.J., Youngken, H.W.
Format: Artikel
Sprache:eng
Schlagworte:
Humans
Hypnotics and Sedatives
Valerian - pharmacology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 244
container_issue 3
container_start_page 240
container_title Journal of pharmaceutical sciences
container_volume 50
creator Rosecrans, J.A.
Defeo, J.J.
Youngken, H.W.
description The roots of Valeriana officinalis were extracted by various solvent extraction procedures and the fractions prepared were tested for their biological activity in an attempt to isolate the most active constituents. Two fractions, V103 and V115, both showed some ability to potentiate the pentobarbital sleeping time in rats. The V115 fraction was also shown to possess greater hypotensive properties than V103. Countercurrent distribution extraction of V115 yielded three fractions, one of which produced hypertensive effects and the other two produced hypotensive effects. Due to inability to reproduce another active V115 fraction, V103 was selected for further testing. The V103 fraction depressed the general activity of rats without producing sleep, exhibited respiratory depressant properties, and produced hypotensive effects in rats, rabbits, cats, and dogs. V103 appears to produce hypotension partly through parasympathomimetic activity and blockage of the carotid sinus reflex. It inhibited the activity of isolated intestinal tissue at low doses and produced a secondary stimulant effect at higher doses which could be blocked by atropine. V103 is relatively nontoxic.
doi_str_mv 10.1002/jps.2600500315
format Article
fullrecord <record><control><sourceid>wiley_cross</sourceid><recordid>TN_cdi_crossref_primary_10_1002_jps_2600500315</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0022354915331129</els_id><sourcerecordid>JPS2600500315</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3975-22a8c016361220bdc57afc1c69703e2472b62bb038dd70e5b1346980b8ef43003</originalsourceid><addsrcrecordid>eNqFkF1LwzAUhoMoOj9uvZT-gc6TpEnaSxk6J2WKHxO8CWmaambXjqRO_fdGOhxeiFcHDs_7wvsgdIxhiAHI6Xzph4QDMACK2RYaYEYg5oDFNhoEgMSUJdke2vd-DgAcGNtFe5iKhFLgA3R186LcQum2bp-tVnU0aVbGd_ZZdbZtoraKRsZ1yjbRTNXGWdWo8Kysto2qrY_yYXT-0TmlO3-IdipVe3O0vgfo4eL8fnQZ59fjyegsjzXNBIsJUakGzCnHhEBRaiZUpbHmmQBqSCJIwUlRAE3LUoBhBaYJz1IoUlMlNMw8QMO-V7vWe2cquXR2odynxCC_pcggRW6khMBJH1i-FQtTbvC1hQBkPfBua_P5T528urn7VR73Wes78_GTVe5VckEFk4_TsZyOZ0-3s6epzAOf9rwJilbWOOm1NY02pXVGd7Js7V87vgCUYY8m</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Pharmacological Investigation of Certain Valeriana officinalis L. Extracts</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Alma/SFX Local Collection</source><creator>Rosecrans, J.A. ; Defeo, J.J. ; Youngken, H.W.</creator><creatorcontrib>Rosecrans, J.A. ; Defeo, J.J. ; Youngken, H.W.</creatorcontrib><description>The roots of Valeriana officinalis were extracted by various solvent extraction procedures and the fractions prepared were tested for their biological activity in an attempt to isolate the most active constituents. Two fractions, V103 and V115, both showed some ability to potentiate the pentobarbital sleeping time in rats. The V115 fraction was also shown to possess greater hypotensive properties than V103. Countercurrent distribution extraction of V115 yielded three fractions, one of which produced hypertensive effects and the other two produced hypotensive effects. Due to inability to reproduce another active V115 fraction, V103 was selected for further testing. The V103 fraction depressed the general activity of rats without producing sleep, exhibited respiratory depressant properties, and produced hypotensive effects in rats, rabbits, cats, and dogs. V103 appears to produce hypotension partly through parasympathomimetic activity and blockage of the carotid sinus reflex. It inhibited the activity of isolated intestinal tissue at low doses and produced a secondary stimulant effect at higher doses which could be blocked by atropine. V103 is relatively nontoxic.</description><identifier>ISSN: 0022-3549</identifier><identifier>EISSN: 1520-6017</identifier><identifier>DOI: 10.1002/jps.2600500315</identifier><identifier>PMID: 13743306</identifier><language>eng</language><publisher>Washington: Elsevier Inc</publisher><subject>Humans ; Hypnotics and Sedatives ; Valerian - pharmacology</subject><ispartof>Journal of pharmaceutical sciences, 1961-03, Vol.50 (3), p.240-244</ispartof><rights>1961 Wiley‐Liss, Inc., A Wiley Company</rights><rights>Copyright © 1961 Wiley‐Liss, Inc., A Wiley Company</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3975-22a8c016361220bdc57afc1c69703e2472b62bb038dd70e5b1346980b8ef43003</citedby><cites>FETCH-LOGICAL-c3975-22a8c016361220bdc57afc1c69703e2472b62bb038dd70e5b1346980b8ef43003</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fjps.2600500315$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fjps.2600500315$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/13743306$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rosecrans, J.A.</creatorcontrib><creatorcontrib>Defeo, J.J.</creatorcontrib><creatorcontrib>Youngken, H.W.</creatorcontrib><title>Pharmacological Investigation of Certain Valeriana officinalis L. Extracts</title><title>Journal of pharmaceutical sciences</title><addtitle>J. Pharm. Sci</addtitle><description>The roots of Valeriana officinalis were extracted by various solvent extraction procedures and the fractions prepared were tested for their biological activity in an attempt to isolate the most active constituents. Two fractions, V103 and V115, both showed some ability to potentiate the pentobarbital sleeping time in rats. The V115 fraction was also shown to possess greater hypotensive properties than V103. Countercurrent distribution extraction of V115 yielded three fractions, one of which produced hypertensive effects and the other two produced hypotensive effects. Due to inability to reproduce another active V115 fraction, V103 was selected for further testing. The V103 fraction depressed the general activity of rats without producing sleep, exhibited respiratory depressant properties, and produced hypotensive effects in rats, rabbits, cats, and dogs. V103 appears to produce hypotension partly through parasympathomimetic activity and blockage of the carotid sinus reflex. It inhibited the activity of isolated intestinal tissue at low doses and produced a secondary stimulant effect at higher doses which could be blocked by atropine. V103 is relatively nontoxic.</description><subject>Humans</subject><subject>Hypnotics and Sedatives</subject><subject>Valerian - pharmacology</subject><issn>0022-3549</issn><issn>1520-6017</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1961</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkF1LwzAUhoMoOj9uvZT-gc6TpEnaSxk6J2WKHxO8CWmaambXjqRO_fdGOhxeiFcHDs_7wvsgdIxhiAHI6Xzph4QDMACK2RYaYEYg5oDFNhoEgMSUJdke2vd-DgAcGNtFe5iKhFLgA3R186LcQum2bp-tVnU0aVbGd_ZZdbZtoraKRsZ1yjbRTNXGWdWo8Kysto2qrY_yYXT-0TmlO3-IdipVe3O0vgfo4eL8fnQZ59fjyegsjzXNBIsJUakGzCnHhEBRaiZUpbHmmQBqSCJIwUlRAE3LUoBhBaYJz1IoUlMlNMw8QMO-V7vWe2cquXR2odynxCC_pcggRW6khMBJH1i-FQtTbvC1hQBkPfBua_P5T528urn7VR73Wes78_GTVe5VckEFk4_TsZyOZ0-3s6epzAOf9rwJilbWOOm1NY02pXVGd7Js7V87vgCUYY8m</recordid><startdate>196103</startdate><enddate>196103</enddate><creator>Rosecrans, J.A.</creator><creator>Defeo, J.J.</creator><creator>Youngken, H.W.</creator><general>Elsevier Inc</general><general>Wiley Subscription Services, Inc., A Wiley Company</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope></search><sort><creationdate>196103</creationdate><title>Pharmacological Investigation of Certain Valeriana officinalis L. Extracts</title><author>Rosecrans, J.A. ; Defeo, J.J. ; Youngken, H.W.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3975-22a8c016361220bdc57afc1c69703e2472b62bb038dd70e5b1346980b8ef43003</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1961</creationdate><topic>Humans</topic><topic>Hypnotics and Sedatives</topic><topic>Valerian - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rosecrans, J.A.</creatorcontrib><creatorcontrib>Defeo, J.J.</creatorcontrib><creatorcontrib>Youngken, H.W.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><jtitle>Journal of pharmaceutical sciences</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rosecrans, J.A.</au><au>Defeo, J.J.</au><au>Youngken, H.W.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacological Investigation of Certain Valeriana officinalis L. Extracts</atitle><jtitle>Journal of pharmaceutical sciences</jtitle><addtitle>J. Pharm. Sci</addtitle><date>1961-03</date><risdate>1961</risdate><volume>50</volume><issue>3</issue><spage>240</spage><epage>244</epage><pages>240-244</pages><issn>0022-3549</issn><eissn>1520-6017</eissn><abstract>The roots of Valeriana officinalis were extracted by various solvent extraction procedures and the fractions prepared were tested for their biological activity in an attempt to isolate the most active constituents. Two fractions, V103 and V115, both showed some ability to potentiate the pentobarbital sleeping time in rats. The V115 fraction was also shown to possess greater hypotensive properties than V103. Countercurrent distribution extraction of V115 yielded three fractions, one of which produced hypertensive effects and the other two produced hypotensive effects. Due to inability to reproduce another active V115 fraction, V103 was selected for further testing. The V103 fraction depressed the general activity of rats without producing sleep, exhibited respiratory depressant properties, and produced hypotensive effects in rats, rabbits, cats, and dogs. V103 appears to produce hypotension partly through parasympathomimetic activity and blockage of the carotid sinus reflex. It inhibited the activity of isolated intestinal tissue at low doses and produced a secondary stimulant effect at higher doses which could be blocked by atropine. V103 is relatively nontoxic.</abstract><cop>Washington</cop><pub>Elsevier Inc</pub><pmid>13743306</pmid><doi>10.1002/jps.2600500315</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-3549
ispartof Journal of pharmaceutical sciences, 1961-03, Vol.50 (3), p.240-244
issn 0022-3549
1520-6017
language eng
recordid cdi_crossref_primary_10_1002_jps_2600500315
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Alma/SFX Local Collection
subjects Humans
Hypnotics and Sedatives
Valerian - pharmacology
title Pharmacological Investigation of Certain Valeriana officinalis L. Extracts
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-18T14%3A58%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-wiley_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacological%20Investigation%20of%20Certain%20Valeriana%20officinalis%20L.%20Extracts&rft.jtitle=Journal%20of%20pharmaceutical%20sciences&rft.au=Rosecrans,%20J.A.&rft.date=1961-03&rft.volume=50&rft.issue=3&rft.spage=240&rft.epage=244&rft.pages=240-244&rft.issn=0022-3549&rft.eissn=1520-6017&rft_id=info:doi/10.1002/jps.2600500315&rft_dat=%3Cwiley_cross%3EJPS2600500315%3C/wiley_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/13743306&rft_els_id=S0022354915331129&rfr_iscdi=true